[1]
S. Ramsay, Élizabeth Naud, D. Simonyan, K. Moore, and S. Bolduc, “A randomized, crossover trial comparing the efficacy and safety of fesoterodine and extended-release oxybutynin in children with overactive bladder with 12-month extension on fesoterodine: The FOXY study”, CUAJ, vol. 14, no. 6, pp. 192–8, Jan. 2020.